Yahoo
    NasdaqGM - Nasdaq Real Time Price USD

    SIGA Technologies, Inc. (SIGA)

    3.0750 +0.1250 (+4.24%)
    As of 2:54:34 PM EST. Market Open.
    Trade SIGA on Coinbase
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for SIGA
    • Previous Close 2.9500
    • Open 2.9700
    • Bid 2.3200 x 200
    • Ask 3.2200 x 400
    • Day's Range 2.9650 - 3.0950
    • 52 Week Range 2.8300 - 8.4600
    • Volume 373,090
    • Avg. Volume 627,764
    • Market Cap (intraday) 220.938M
    • Beta (5Y Monthly) 1.04
    • PE Ratio (TTM) --
    • EPS (TTM) -0.0400
    • Earnings Date Nov 9, 2026
    • Forward Dividend & Yield -- (0.00%)
    • 1y Target Est --
    • Motley Fool Rating Bearish

    SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

    www.siga.com

    49

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about SIGA Technologies, Inc.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

    YTD Return

    SIGA
    43.11%
    S&P 500 (^GSPC)
    10.45%

    1-Year Return

    SIGA
    57.61%
    S&P 500 (^GSPC)
    10.35%

    3-Year Return

    SIGA
    19.51%
    S&P 500 (^GSPC)
    73.48%

    5-Year Return

    SIGA
    36.20%
    S&P 500 (^GSPC)
    62.23%

    Earnings Trends

    View More

    Earnings Per Share

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q1 FY23
    Revenue 8.32M
    Earnings -918.26k
    Profit Margin -11.03%

    Q1

    FY14

    Q2

    FY21

    Q3

    FY22

    Q1

    FY23

    0
    10M
    20M
    30M
    -10.0%
    -8.0%
    -6.0%
    -4.0%
    -2.0%
    0.0%
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      -5.19%

    • Return on Assets (ttm)

      -3.39%

    • Return on Equity (ttm)

      -1.49%

    • Revenue (ttm)

      53.66M

    • Net Income Avi to Common (ttm)

      -2.79M

    • Diluted EPS (ttm)

      -0.0400

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      117.58M

    • Total Debt/Equity (mrq)

      0.27%

    • Levered Free Cash Flow (ttm)

      -23.99M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    GOVX
    VERU
    EBS
    BVNRY
    RIGL
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: